More Than 100 Applications Lost Equivalence Rating Thanks To Allegedly Falsified Data At Two CROs

 
• By Derrick Gingery
  
computer security
Because the data integrity of some studies came into question, the FDA said all data from two CROs was not reliable. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics